Benzonatate Capsule Manufacturing

This subcontract involves the manufacture and supply of 100 mg Benzonatate Capsules, USP, for prime contractors supporting Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The scope of work includes the formulation and encapsulation of the active ingredient according to USP standards, with final products delivered in 100 count bottles. All packaging must adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E. To qualify, the provider must operate out of an FDA-approved facility and maintain strict cGMP compliance. The performance of this contract is centered at Fort Campbell, Kentucky. Interested parties should note the response deadline of October 28, 2026, for this pharmaceutical manufacturing requirement under NAICS code 325412.